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Background and Aim. EUS-guided intervention (EGI) for biliary therapy has been increasingly used in recent years. This report
aims to describe the spectrum and experience of EUS-guided interventions in biliary diseases in a single-tertiary center. Methods.
All patients with EGI were analyzed retrospectively by retrieving data from a prospectively stored endoscopic database between
January 2006 and September 2010. Results. There were 31 cases with EGIs (17 female, 14 male) with a mean age ± SD of 58.03
± 16.89 years. The majority of cases (17/31; 55%) were ampullary or pancreatic cancers with obstructive jaundice. The major
indications for EGI were obstructive jaundice (n = 16) and cholangitis (n = 9). The EGIs were technically successful in 24 of the
31 cases (77%). The success rate for the ﬁrst 3 years was 8 of 13 procedures (61.5%) as compared to that of the last 2 years (16/18
procedures (89%); P = 0.072). Twenty-three of the 24 cases (96%) with technical success for stent placement also had clinical
success in terms of symptom improvement. The complications were major in 4 (13%) and minor in 7 (23%) patients. Conclusion.
The EUS-guided drainage for biliary obstruction, acute cholecystitis, bile leak, and biloma was an attractive alternative and should
be handled in expert centers.
1.Introduction
Endoscopic ultrasound (EUS) guided cholangiography was
ﬁrstlyreportedin1996[1].EUS-guidedinterventions(EGIs)
have been increasingly used in recent years [2, 3]. Many
reportspertaining toEUS-guidedbiliarydrainage inpatients
with failed ERCP, acute cholecystitis, and bilomas are
available in the literature [4–36]. This report describes the
spectrum and experience of EUS-guided interventions in
biliary diseases in our center.
2. Methods
This is a retrospective analysis of a prospectively stored en-
doscopic database from 2006 till September 2010. The study
was approved by our institutional ethics committee. All
of the endoscopic reports of EUS-guided interventions in
biliary diseases were retrieved, and all of the endoscopic
reports and medical records were reviewed. Data regarding
the demographic proﬁles, indications, procedure types, tech-
nical success, clinical success, complications, and outcome of
patients were analyzed.
ThemainindicationsforEGIsofbiliarydiseasesincluded
patients with failed ERCPs for biliary therapy, patients with
surgically altered anatomy preventing accessible ERCP, the
unﬁt-for-surgery patients with cholecystitis not responding
to medical treatment, and one patient with biloma requiring
drainage. The EUS-guided intervention was performed
using the Olympus EUS scope (GF-UCT160OL5, Olympus
Medical, Tokyo, Japan) with a 3.7mm working channel by2 Gastroenterology Research and Practice
two authors (S. Attasaranya and B. Ovartlarnporn). All of
the procedures were carried out under conscious sedation
with midazolam and pethidine supplemented with propofol
where necessary, except one case (an 11-year-old girl) under
general anesthesia. The common bile duct (CBD) was
preferred as an access route in patients with distal bile duct
obstruction, while the left intrahepatic duct was selected as
an access point in patients with hilar obstruction, surgically
altered anatomy, or narrowing of the pylorus preventing the
EUS scope from passing into the proper position in the duo-
denum.Thebileductwaspuncturedusinga19-gaugeneedle
(Echotip Wilson-Cook Medical, Winston-Salem, NC). After
conﬁrmation of the proper position of the needle in the
bile duct by aspiration for bile and contrast injection, a
0.035  -guidewire (Jagwire Boston Scientiﬁc, Miami, FL) was
inserted through the needle until several loops of the wire
werecoiledinthebileduct.Theneedlewasremoved,andthe
needle tract was dilated using an ERCP catheter followed by
6 Fr and 7 Fr dilating catheters (Soehendra dilation catheter,
Wilson-Cook Medical) over the guidewire. A 7 Fr double-
pigtail plastic stent (Zimmon biliary stent, Wilson-Cook
Medical) or a partially covered metallic stent (Wallstent,
Boston Scientiﬁc) was then inserted. If the needle tract
dilatation using an ERCP catheter was unsuccessful, a needle
knife (Microknife, Boston Scientiﬁc, Spencer, IN) using the
endocut mode (VIO 300D, ERBE Elektromedizin GmbH,
T¨ ubingen, Germany) over the wire, was then introduced
into the bile duct, and the tract was further dilated with 6
Fr and 7 Fr dilating catheters or an 8 mm biliary dilation
balloon(Hurricaneballooncatheter,BostonScientiﬁc,Cork,
Ireland). The procedures were performed in an out-patient
setting in 4 cases and in an in-patient setting in 27 cases.
The technical success was deﬁned as a successful proce-
durewithaproperlyplacedstent,whereastheclinicalsuccess
as the improvement of the symptoms intended to be treated
by the procedure. The reduction of serum bilirubin level by
a value greater than 50% measured after 2 weeks after the
procedure as compared to the baseline value was deﬁned as
successful drainage for patients with obstructive jaundice.
The complications that required surgical interventions
were deﬁned as major complications, and those that
recovered spontaneously or responded to medical therapy
or minimally invasive procedures were deﬁned as minor
complications.
3. Results
A total of 31 cases (17 female and 14 male) underwent EUS-
guided interventions during the period under investigation.
The mean age ± SD was 58.0 ± 16.9 years, with a range of
11 to 88 years. The median follow-up time in the 28 patients
with available follow-up data was 3.4 months, with a range
of0.3–21.5months.Fourteenpatientsdied,tenpatientswere
still alive, and seven patients defaulted during the followup.
The diagnoses of the patients comprised periampullary
or pancreatic cancer in 17, gastric cancer in 1, duodenal
cancer in 1, pancreatic inﬂammatory pseudotumor in 1,
metastatic cancer in 2, choledochojejunostomy stenosis in 3,
Table 1: Indications for EUS-guided interventions.
Indication Number of cases
Obstructive jaundice 16
Cholangitis 9
Cholecystitis 2
Choledochojejunostomy stenosis 1
PTBD replacementf 1
Bile leak 1
Biloma 1
fPercutaneous transhepatic biliary drainage.
Table 2: Type of drainage, success rate, and type of stent inserted.
Type of procedure No. Success
Hepaticogastrostomy 16 13
Choledochoduodenostomy 9 5
Cholecystoduodenostomy 4 3
Biloma drainage 1 1
Antegrade placement of metallic stent in
CBD through the duodenal wall 11
Total 31 24
Type of stent
Plastic, double pigtail 22
Metallic, partially covered 4
gallstone with cholecystitis in 1, post ERCP cholecystitis in 1,
CBD stone in 1, bile leak in 1, hilar cholangiocarcinoma in 1,
and biloma with postlaparoscopic cholecystectomy bile leak
in 1.
Theindicationsforendoscopicdrainagewereobstructive
jaundice in 16, cholangitis in 9, cholecystitis in 2, choledo-
chojejunostomy stenosis in 1, replacement of percutaneous
transhepatic biliary drainage (PTBD) in 1, bile leak in 1, and
b i l o m ai n1( Table 1). The reasons for EUS-guided drainage
were failed ERCP for biliary cannulation in 14, inaccessible
ERCP due to luminal stenosis secondary to tumor invasion
of gastric antrum or duodenum in 10, surgically altered
anatomy in 4, acute cholecystitis with unﬁt condition for
surgery in 2, and biloma in 1.
The EUS-guided interventions (EGIs) were technically
successful in 24 of 31 (77%) cases. Twenty-three (96%) of
those with technical success for EGIs had clinical success
in terms of symptoms improvement also. There were 16
hepaticogastrostomies (HG) with 3 failures, 9 choledo-
choduodenostomies (CD) with 3 failures, 4 cholecystoduo-
denostomies (CHD) with 1 failure, 1 antegrade placement
of metallic stent in CBD through the duodenal wall, and
1 biloma drainage performed. Covered metallic stents were
inserted in4patients andplastic stents in22others (Table 2).
ThefailureratesintheHGandnon-HGprocedureswere3in
16 (19%) and 4 in 15 (27%), respectively, but the diﬀerence
was not statistically signiﬁcant. There were 5 failures out of
13 procedures done in the ﬁrst 3 years (38%) and 2 failures
out of 18 procedures in the last 2 years (11%); the diﬀerence
wasnotsigniﬁcant(P = 0.072).ThemeanhospitalstayintheGastroenterology Research and Practice 3
Table 3: Complications, treatment, and outcomes.
Number Outcome
Major complications in technical
success
Stent slipped oﬀ 2d a y sl a t e r 1 Surgery done,
recovered
Major complications in technical
failure
Metallic stent deployed outside
gastric wall 1 Surgery done,
recovered
Duodenal perforation 1 Surgery done,
recovered
Bile peritonitis 1 Surgery done,
deteriorated
Total major complications 4
Minor complications in technical
success
Severe abdominal pain 1 Resolved with
medical treatment
Postprocedure fever 2 Recovered with
antibiotics
Mild abdominal pain 1 Recovered
Retrogastric collection 1 Recovered with
PCD+
Minor complications in technical
failure
Bleeding 1 Stopped
spontaneously
Postprocedure fever 1 Recovered with
antibiotics
Total minor complications 7
Total overall complications 11 10 with recovery
+Percutaneous drainage.
27 patients on whom procedures were performed in an in-
patient basis was 16.8 ± 28.6 days. In the subgroup analysis
to compare the mean hospital stay between the patients
with successful (N = 20) and those with failed procedures
(N = 7), no statistical diﬀerence between the two groups was
observed (17.3 ±33.3v e r s u s1 5 .1 ±6.3d a y s ;P = 0.78).
There were 11 complications in the 31 procedures (35%)
as shown in Table 3. The complications were major in 4
(13%) and minor in 7 (23%) cases. In subgroup analysis, 2
major and 2 minor complications occurred in the patients
with EUS-guided CD, while 1 major and 5 minor compli-
cations occurred in those with EUS-guided HG. There was
no statistical diﬀerence of complication rate between the
two groups (P = 0.527). The four major complications
included delayed migration of the stent out of the bile
duct leading to bile peritonitis requiring surgery for biliary
diversion in 1, malposition of stent deployment resulting
one tip of the stent located in intraperitoneum requiring
surgery to retrieve the stent into a proper position in 1,
perforation induced by the EUS scope requiring surgical
repair in 1, and bile peritonitis after failed EUS-guided CHD
requiring surgical intervention in 1. All but one patient
recovered following surgical intervention. The patient with
bile peritonitis after the failed EUS-guided CHD had a
stormy, deteriorating postoperative course. The patient was
eventually referred to a local facility for best supportive
care in accordance with the patient and his family’s wish.
The minor complications included severe abdominal pain
with pneumoperitoneum that subsided with conservative
treatment in 1, postprocedure fever in 3, minor abdominal
pain in 1, infected retrogastric collection resolved by medical
therapy with percutaneous drainage in 1, and self-limited
bleeding at the puncture site in 1. The complication rate
for the ﬁrst 3 years was 7 of 13 procedures (54%), which
trended to be higher than that for the last two years (4 of
18 procedures; 22.2%) but with no statistical insigniﬁcance
(P = 0.087).
Stent exchange was required in 3 patients during the
followup. One patient with metastatic gastric cancer had the
stent occluded at 3-month intervals and required another
EUS-guided metallic stent placement. Another patient with
recurrent pancreatic cancer after Whipple’s operation under-
went a biliary plastic stent exchange 2 months after the
procedure. The third patient with a stricture during hepati-
cojejunostomy was treated with percutaneous placement of
a metallic stent elsewhere, but the stent was blocked, leading
to cholangitis. The stent was partially removed using single-
balloon enteroscopy followed with EUS-guided HG with a
metallic stent placement. Cholangitis resolved, but the new
stent was occluded 3 weeks later. The repeated endoscopy
revealed that the tip (gastric side) of the stent was found to
be too long and submersed under gastric juice. Trimming of
the stent tip with argon plasma was performed, and the stent
was then cleaned by repeated balloon sweeping. However,
multiple episodes of stent occlusion still recurred, requiring
additional plastic stent insertion. The patient defaulted after
a 9-month followup following the ﬁrst procedure. Three
patients, two with acute cholecystitis and one with biloma,
had their stents removed after the resolution of symptoms.
All of the stents in the remaining 17 patients with successful
procedures were still functioning at the time of the last
followup.
4. Discussion
The EUS-guided interventions for biliary diseases were
demonstrated to be an attractive alternative in our report.
The overall technical success rate in our study was in the
boundary of the 50–100% range that is reported in the
literature [4–36]. In the study by Itoi et al. [16], the technical
success rate for EUS-guided HG ranged from 91–100%, and
the success rate of EUS-guided CD ranged from 50–100%.
The 81% success rate for the former and the 67% success rate
for the latter in our series were similar to the data reported
in the literature. The higher success rate for EUS-guided HG
suggested that it may be easier to perform than EUS-guided
CD, which was in agreement with other reports [34]. The
failurerateof38%intheinitial3yearscomparedwiththatof
11% in the last 2 years suggested that a learning curve period
was required to improve technical skill. Notably, our success4 Gastroenterology Research and Practice
rate of 89% in the last 2 years was comparable to the ranges
reported in other series [16].
The EUS-guided drainage of the gallbladder (GB) in
our report showed the potential use of this approach in
treating selected patients with acute cholecystitis. Only a
few reports with a small number of patients have reported
the utility of EUS-guide drainage of the GB in cholecystitis
[21–24, 32, 33]. In the literature review by Itoi et al. [22],
24 cases were reported with EUS-guided drainage of the
GB in acute cholecystitis, with clinical success in all cases
and a 25% complication rate. Recently, Itoi et al. have
reported a case series of 5 patients with acute cholecystitis
successfully treated via EUS-guided GB drainage using novel
fullycoveredmetallicstentsdesignedtohavebilateralanchor
ﬂanges [37]. Interestingly, the stent stayed fully patent for
12 months in a patient whose GB stent remained dwelling.
Thebeneﬁtoflong-termGBstentinginthissetting,however,
n e e d st ob ed e t e r m i n e db yf u r t h e rs t u d y .
The EUS-guided drainage of the GB without acute
cholecystitis was performed on 2 patients in our report. One
patient with failed ERCP intervention causing subsequent
bile leak showed resolution of the leakage following EUS-
guided GB drainage. The other patient with obstructive
jaundice from malignant distal bile duct stricture, whose HG
and CD could not be performed due to the small degree
of upstream duct dilation, failed the EUS-guided drainage
of the GB and developed bile leak from the punctured GB
leading to a dismal outcome. In detail, the failure in this
patient occurred due to the dislodgement of the proximal
tip of the stent out of the GB during stent deployment.
Subsequent attempts at EUS-guided puncturing of the GB
for another stent placement were unsuccessful presumably
due to the collapsed GB following the leak. To the best of
our knowledge, there has been no report regarding EUS-
guided drainage of the GB without acute cholecystitis. For
noninﬂamed GB, EUS-guided drainage should be done
with caution since the GB is mobile; thus, the procedure
may be more challenging, and the risk of bile leakage into
the peritoneum is theoretically higher than that involving
cases of inﬂamed GB, in which the surrounding adhesion
may prevent bile leakage into the peritoneal cavity. Further
reﬁnement regarding the techniques and development of
accessories for the procedure are needed before EUS-guided
drainage of the GB can be accepted as a standard option.
EUS-guided drainage of the bile duct in patients with
surgically altered anatomy was carried out in 4 patients
and all of them experienced technical success. One of our
patients had an ERCP performed using a single balloon
enterosope, but only partial removal of the blocked metallic
stent was accomplished. The EUS-guided drainage provided
some additional treatment, but it did not completely solve
the problem of recurrent stent occlusion. Two of our patients
underwent EUS-guided bile duct drainage for anastomosis
stricture. In one of the two patients, the stricture was
dilated with a biliary balloon, and a concomitant bile duct
stone was successfully pushed through the anastomosis into
the jejunal limb using a balloon resulting in improved
symptoms. Another patient underwent an HG and waited
for the tract to mature before tract dilatation to deal with
the stricture. In another patient, the EUS-guided drainage
was used to replace the preexisting PTBD to improve quality
of life, but the stent became malfunctional at 4 weeks
after insertion. A PTBD was eventually required for biliary
drainage. The ultimate role of EUS-guided drainage in
patients with surgically altered anatomy as compared with
ERCP by a balloon enteroscope or a percutaneous approach
needs further study for clariﬁcation.
One patient with biloma was successfully drained by
the EUS-guided approach in this report. Shami et al. has
reported on EUS-guided drainage of biloma with a clinical
response in 5 patients [31]. EUS-guided drainage of bilomas
istechnicallyfeasible,appearssafe,andprovidesanattractive
alternative to other treatment modalities.
The overall complication rate of EUS-guided interven-
tion of 35% in this report was within the range reported
in the literatures [4–36]. However, the complication rate
of 0–36.3% reported in the literatures may be an under
estimation, since series with unfavorable outcome are more
likely to be unreported. Most of the complications in our
series were minor, but the 4 (13%) major complications are
of concern. Three out of 4 major complications occurred
following technical failure (Table 3). Notably, two of the
major complications were related to stent displacement;
one was related to delayed dislodgment of a double-pigtail
plastic stent out of the common bile duct in the patient
undergoing an EUS-guided CD, and the other was related
to the improperly placed metallic stent with the proximal
end dislodged into the intra-abdominal cavity. In order
to prevent stent dislocation/migration, some experts have
suggested that a relatively longer plastic stent is preferable,
particularlywhenplacingviaaHGapproach.Theshortening
ratio of the metallic stent should also be taken into account
when placing the braided-type metallic stent [38].
The complication rate declining from 53% in the ﬁrst
3 years to 22% in the last 2 years might imply that more
experience resulted in a more favorable outcome.
Thelonger-thanexpectedhospitalstay(mean16.8±28.6
days) in our study was due to multiple contributing factors
mostly unrelated to the procedures per se. Most patients
required concomitant therapy for their underlying medical
conditions as well as chemotherapy for the underlying
malignancies.
In conclusion, our data suggest that EUS-guided biliary
intervention is feasible and an attractive alternative tool
providing biliary drainage in selected patients and should be
performed by experienced endoscopists.
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